AlphaStocks
5.7
Consider Buy

Alkermes plc. (ALKS)

Health Care / Pharmaceuticals

S&P SmallCap 600

$35.05

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 4 of 5 models — moderate confidence

#375out of 1127 in Health Care

Is Alkermes plc. a Good Investment in 2026?

Alkermes plc. (ALKS) scores 5.7 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Lynch model rates Alkermes plc. as Strong (PEG 0.8 · Fast Grower). However, the Graham model rates it Caution — 25% above fair value. Alkermes plc. currently trades below its estimated fair value of $37, suggesting potential upside. Alkermes plc. ranks #375 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E24.5ROE8.1Market Cap6B

Estimated Fair Value

$37.126% below

Trading near or slightly below estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

25% above fair value

Lynch

Strong

PEG 0.8 · Fast Grower

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is Alkermes plc. (ALKS) a good investment?
Based on AlphaStocks' composite analysis, Alkermes plc. (ALKS) scores 5.7 out of 10, earning a Consider Buy rating. This is a middle-of-the-pack score with no strong signal either way. Trading near or slightly below estimated fair value.
What is Alkermes plc.'s Piotroski F-Score?
Alkermes plc.'s Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is ALKS overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $37, ALKS appears undervalued. The stock currently trades 6% below its estimated fair value. Trading near or slightly below estimated fair value.
How does ALKS compare to other Health Care stocks?
Alkermes plc. ranks #375 out of 1127 stocks in the Health Care sector, placing it in the top 33% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about ALKS?
AlphaStocks evaluates ALKS using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Caution; Lynch: Strong. These models are combined into a single composite score of 5.7/10.

Similar Stocks

PARRFTIAZN

Compare ALKS with

ALKS vs PARRALKS vs FTIALKS vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer